Celon Pharma
↗Łomianki, Poland
Celon Pharma S.A. is an integrated Polish biopharmaceutical company founded in 2002, specializing in the research, development, and manufacturing of both generic and innovative medicinal products. The company operates a hybrid business model, utilizing cash flow from its generic portfolio (focused on oncology, CNS, and respiratory) to fund a highly innovative pipeline of small molecules and biologics.
Headquartered near Warsaw, the company maintains advanced R&D centers and GMP-certified manufacturing facilities. Its strategic focus lies in high-unmet-need areas including neuropsychiatry, metabolic diseases, oncology, and inflammatory disorders. Celon Pharma is publicly traded on the Warsaw Stock Exchange and has recently expanded its global footprint through strategic US-based joint ventures for late-stage clinical development.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:CNS and Metabolic Therapeutics
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:2002
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$150M+
Investors:Tang Capital Management, Plexus Ventures, National Centre for Research and Development (Poland)
STOCK
Exchange:WSE
Ticker:CLN
Market Cap:$300M
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Falkieri)
Modalities:Small molecule, Dry Powder Inhalation (DPI), mRNA, Recombinant proteins
Active Trials:8
Trial Phases:Phase 1: 3 | Phase 2: 4 | Phase 3: 1
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Novohale Therapeutics, LLC (US Joint Venture)
Key Partnerships:Tang Capital Management (Novohale JV for Falkieri), Simcere Pharmaceutical (China rights for specific assets)
COMPETITION
Position:Challenger
Competitors:Janssen (Spravato), Intra-Cellular Therapies, Acadia Pharmaceuticals, Glenmark Pharmaceuticals, Adamed Pharma
LEADERSHIP
Key Executives:
Maciej Wieczorek - CEO & Founder
Jacek Glinka - Vice President
Bogdan Manowski - Director of Business Development
Scientific Founders:Maciej Wieczorek
Board Members:Maciej Wieczorek, Jacek Glinka, Iwona Giedronowicz
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Celon Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.